OBJECTIVES: To examine the relationship between 25-hydroxyvitamin D (25(OH)D) levels and cognitive performance over time in older adults in the Health, Aging and Body Composition (Health ABC) Study. DESIGN: Prospective cohort study. SETTING: Community-dwelling participants in Pittsburgh, Pennsylvania, and Memphis, Tennessee. PARTICIPANTS: Well-functioning adults aged 70 to 79 at baseline with serum 25(OH)D measured at the 12-month follow-up visit and cognitive function measured at baseline and 4-year follow-up visit (N = 2,777). MEASUREMENTS: Vitamin D status was categorized as 25(OH)D levels of less than 20.0 ng/mL, 20.0 to 29.9 ng/mL, or 30.0 ng/mL or greater. Cognition was measured using the modified Mini-Mental State Examination (3MS) and Digit Symbol Substitution Test (DSST). Linear regression models adjusting for multiple covariates, including age, education, sex, race, site, season, physical activity, and comorbidities, were used in the analysis. RESULTS: Sixty-eight percent of participants had 25(OH)D levels of less than 30.0 ng/mL. Lower 25(OH)D levels were associated with lower baseline cognitive scores on the 3MS (adjusted mean 89.9, 95% confidence interval (CI) = 89.4-90.4 for <20.0 ng/mL; adjusted mean 90.8, 95% CI = 90.4-91.3 for 20.0-29.9 ng/mL; adjusted mean 90.6, 95% CI = 90.2-91.1 for ≥ 30.0 ng/mL; P trend = .02) and the DSST (adjusted mean 35.2, 95% CI = 34.5-36.0 for <20.0 ng/mL; adjusted mean 35.9, 95% CI = 35.2-36.6 for 20.0-29.9 ng/mL; adjusted mean 37.0, 95% CI = 36.3-37.8 for ≥ 30.0 ng/mL; P trend = .01). Participants with low 25(OH)D levels had greater declines in 3MS scores over 4 years than those with higher levels (least square mean change -1.0, 95% CI = -1.5 to -0.6 for <20.0 ng/mL; least square mean change -0.8, 95% CI = -1.2 to -0.3 for 20.0-29.9 ng/mL; least square mean change -0.2, 95% CI = -0.7 to 0.2 for ≥30.0 ng/mL; P = .05). There was no significant difference in DSST decline according to 25(OH)D level. CONCLUSION: Low 25(OH)D levels were associated with worse global cognitive function and greater decline over time according to the 3MS. Intervention trials are needed to determine whether vitamin D supplementation can reduce cognitive decline.
OBJECTIVES: To examine the relationship between pan class="Chemical">25-hydroxyvitamin D (25(OH)D) levels and cognitive performance over time in older adults in the Health, Aging and Body Composition (Health ABC) Study. DESIGN: Prospective cohort study. SETTING: Community-dwelling participants in Pittsburgh, Pennsylvania, and Memphis, Tennessee. PARTICIPANTS: Well-functioning adults aged 70 to 79 at baseline with serum 25(OH)D measured at the 12-month follow-up visit and cognitive function measured at baseline and 4-year follow-up visit (N = 2,777). MEASUREMENTS: Vitamin D status was categorized as 25(OH)D levels of less than 20.0 ng/mL, 20.0 to 29.9 ng/mL, or 30.0 ng/mL or greater. Cognition was measured using the modified Mini-Mental State Examination (3MS) and Digit Symbol Substitution Test (DSST). Linear regression models adjusting for multiple covariates, including age, education, sex, race, site, season, physical activity, and comorbidities, were used in the analysis. RESULTS: Sixty-eight percent of participants had 25(OH)D levels of less than 30.0 ng/mL. Lower 25(OH)D levels were associated with lower baseline cognitive scores on the 3MS (adjusted mean 89.9, 95% confidence interval (CI) = 89.4-90.4 for <20.0 ng/mL; adjusted mean 90.8, 95% CI = 90.4-91.3 for 20.0-29.9 ng/mL; adjusted mean 90.6, 95% CI = 90.2-91.1 for ≥ 30.0 ng/mL; P trend = .02) and the DSST (adjusted mean 35.2, 95% CI = 34.5-36.0 for <20.0 ng/mL; adjusted mean 35.9, 95% CI = 35.2-36.6 for 20.0-29.9 ng/mL; adjusted mean 37.0, 95% CI = 36.3-37.8 for ≥ 30.0 ng/mL; P trend = .01). Participants with low 25(OH)D levels had greater declines in 3MS scores over 4 years than those with higher levels (least square mean change -1.0, 95% CI = -1.5 to -0.6 for <20.0 ng/mL; least square mean change -0.8, 95% CI = -1.2 to -0.3 for 20.0-29.9 ng/mL; least square mean change -0.2, 95% CI = -0.7 to 0.2 for ≥30.0 ng/mL; P = .05). There was no significant difference in DSST decline according to 25(OH)D level. CONCLUSION: Low 25(OH)D levels were associated with worse global cognitive function and greater decline over time according to the 3MS. Intervention trials are needed to determine whether vitamin D supplementation can reduce cognitive decline.
Authors: Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver Journal: J Clin Endocrinol Metab Date: 2011-06-06 Impact factor: 5.958
Authors: Denise K Houston; Janet A Tooze; Dorothy B Hausman; Mary Ann Johnson; Barbara J Nicklas; Michael E Miller; Rebecca H Neiberg; Anthony P Marsh; Anne B Newman; Steven N Blair; Stephen B Kritchevsky Journal: J Gerontol A Biol Sci Med Sci Date: 2011-02-16 Impact factor: 6.053
Authors: J van der Schaft; H L Koek; E Dijkstra; H J J Verhaar; Y T van der Schouw; M H Emmelot-Vonk Journal: Ageing Res Rev Date: 2013-05-29 Impact factor: 10.895
Authors: Rebecca C Rossom; Mark A Espeland; Joann E Manson; Maurice W Dysken; Karen C Johnson; Dorothy S Lane; Erin S LeBlanc; Frank A Lederle; Kamal H Masaki; Karen L Margolis Journal: J Am Geriatr Soc Date: 2012-11-23 Impact factor: 5.562
Authors: David B Matchar; Choy-Lye Chei; Zhao-Xue Yin; Victoria Koh; Bibhas Chakraborty; Xiao-Ming Shi; Yi Zeng Journal: J Gerontol A Biol Sci Med Sci Date: 2016-07-12 Impact factor: 6.053
Authors: Caroline S Duchaine; Denis Talbot; Mohamed Nafti; Yves Giguère; Sylvie Dodin; André Tourigny; Pierre-Hugues Carmichael; Danielle Laurin Journal: Can J Public Health Date: 2020-02-03
Authors: Laurel Kilpatrick; Denise K Houston; Valerie K Wilson; James Lovato; Hilsa N Ayonayon; Jane A Cauley; Tamara Harris; Eleanor M Simonsick; Kristine Yaffe; Stephen B Kritchevsky; Kaycee M Sink Journal: J Nutr Gerontol Geriatr Date: 2018-03-05
Authors: Margot J Overman; Neil Pendleton; Terence W O'Neill; Gyorgy Bartfai; Felipe F Casanueva; Joseph D Finn; Gianni Forti; Giulia Rastrelli; Aleksander Giwercman; Thang S Han; Ilpo T Huhtaniemi; Krzysztof Kula; Michael E J Lean; Margus Punab; David M Lee; Elon S Correa; Tomas Ahern; Sabine M P Verschueren; Leen Antonio; Evelien Gielen; Martin K Rutter; Dirk Vanderschueren; Frederick C W Wu; Jos Tournoy Journal: Eur J Nutr Date: 2016-07-01 Impact factor: 5.614
Authors: A Granic; T R Hill; T B L Kirkwood; K Davies; J Collerton; C Martin-Ruiz; T von Zglinicki; B K Saxby; K A Wesnes; D Collerton; J C Mathers; C Jagger Journal: Eur J Neurol Date: 2014-08-13 Impact factor: 6.089
Authors: Sharmin Hossain; Michele K Evans; Alan B Zonderman; May A Beydoun; Jordan Weiss; Marie F Kuczmarski Journal: Br J Nutr Date: 2020-04-06 Impact factor: 3.718